Wave Life Sciences, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-204.4M | $-97.0M | $-57.5M | $-161.8M | $-122.2M | $-149.9M | $-193.6M | $-146.7M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $3.4M | $3.9M | $5.0M | $6.6M | $7.5M | $8.1M | $7.6M | $5.6M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-187.5M | $-151.0M | $-19.4M | $-127.8M | $-89.0M | $-116.0M | $-188.2M | $-22.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $718.0K | $938.0K | $1.1M | $1.4M | $560.0K | $1.3M | $3.9M | $9.9M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-718.0K | $-938.0K | $-1.1M | $-1.3M | $-560.0K | $-1.3M | $-3.9M | $-9.9M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $488.2M | $253.9M | $132.5M | $67.2M | $55.8M | $154.5M | $164.4M | $65.1M |
| Net Change in Cash | $300.0M | $101.8M | $111.9M | $-62.1M | $-33.9M | $37.3M | $-27.6M | $32.3M |
| Free Cash Flow | $-188.2M | $-152.0M | $-20.5M | $-129.1M | $-89.6M | $-117.3M | $-192.1M | $-32.8M |